Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05970549 · ClinicalTrials.gov registry record · NA
Intraventricular Catheter System for IVH
A NA study of Intraventricular Hemorrhage (IVH), sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT05970549: Recruiting NA study of Intraventricular Hemorrhage (IVH), sponsored by Icahn School of Medicine at Mount Sinai.
NCT05970549 is a NA study of Intraventricular Hemorrhage (IVH) that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05970549, a NA study of Intraventricular Hemorrhage (IVH), is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the safety and outcomes associated with the use of IRRAflow® System catheters in externally draining intracranial fluid to reduce intracranial pressure. This study will be comparing the IRRAflow® system to standard of care catheters used in the same procedure. The IRRAflow® system is FDA approved for this procedure.
Primary Outcome
Residual blood volume on post bleed day 5
Conditions Studied
Interventions
- DEVICE IRRAflow® Active Fluid Exchange System
- DEVICE Traditional extraventricular drain
- PROCEDURE Non-contrast head CTs
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-06-14 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05970549 shows while recruiting
NCT05970549 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Intraventricular Hemorrhage (IVH) appearing as the primary indexed condition, and to 3 interventions - of which IRRAflow® Active Fluid Exchange System is the first listed.
NCT05970549 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05970549 about?
NCT05970549 is a clinical study titled "Intraventricular Catheter System for IVH". The purpose of this research study is to evaluate the safety and outcomes associated with the use of IRRAflow® System catheters in externally draining intracranial fluid to reduce intracranial pressure. This study will be comparing the IRRAflow® system to standard of care catheters used in the same ...
What is the current status of trial NCT05970549?
This trial is currently recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2022-06-14. Estimated completion is 2026-12-31.
What conditions does trial NCT05970549 study?
This clinical trial studies the following conditions: Intraventricular Hemorrhage (IVH).
What interventions are being tested in trial NCT05970549?
The interventions under investigation include: IRRAflow® Active Fluid Exchange System (DEVICE), Traditional extraventricular drain (DEVICE), Non-contrast head CTs (PROCEDURE).
Who is sponsoring clinical trial NCT05970549?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05970549 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraventricular Hemorrhage (IVH)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05970549's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI